Your browser doesn't support javascript.
Incidence of Olfactory Dysfunction in Patients with COVID-19 in a Tertiary Hospital in Saudi Arabia.
Alfallaj, Rayan; AlSkait, Ghada; Alamari, Nouf; Alfawzan, Lama; Abualgasem, Mohammed; Alotaibi, Naif H; Sumaily, Ibrahim; Alarifi, Ibrahim; Alsaleh, Saad.
  • Alfallaj R; Otolaryngology-Head & Neck Surgery Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • AlSkait G; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alamari N; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Alfawzan L; College of Medicine, King Saud University, Riyadh, Saudi Arabia.
  • Abualgasem M; College of Medicine, Jazan University, Jazan, Saudi Arabia.
  • Alotaibi NH; ENT Department, King Faisal Specialist Hospital, Riyadh, Saudi Arabia.
  • Sumaily I; ENT Department, King Fahd Central Hospital, Jazan, Saudi Arabia.
  • Alarifi I; ENT Department, Security Forces Hospital, Riyadh, Saudi Arabia.
  • Alsaleh S; Otolaryngology-Head & Neck Surgery Department, College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Allergy Rhinol (Providence) ; 13: 21526575221140809, 2022.
Article in English | MEDLINE | ID: covidwho-2307196
ABSTRACT

Background:

Coronavirus disease (COVID-19) is caused by the severe acute respiratory syndrome coronavirus 2, a novel virus that emerged in China in December 2019. In many cases of COVID-19, olfactory dysfunction (OD) is the only symptom.

Objectives:

This study aimed to examine the incidence of OD in patients with COVID-19 and identify an association between OD and COVID-19-related morbidity and admission.

Design:

This was a cross-sectional study.

Methods:

Real-time reverse transcription polymerase chain reaction-confirmed cases of COVID-19 from the Security Forces Hospital electronic registry from June 2020 to September 2020 were included in our study. Data on medical background, severity of the disease, and other related factors were collected through phone calls and electronic healthcare systems and analyzed to investigate OD in the participants.

Results:

Of the participants, 68% had OD, with a mean recovery time of 18 days and a mean follow-up time of 129 days (76-211 days). OD was negatively correlated with admission and morbidity.

Conclusion:

OD is a common presentation of COVID-19 and is more prevalent in mild cases of infection.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Allergy Rhinol (Providence) Year: 2022 Document Type: Article Affiliation country: 21526575221140809

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Cohort study / Observational study / Prognostic study / Randomized controlled trials Language: English Journal: Allergy Rhinol (Providence) Year: 2022 Document Type: Article Affiliation country: 21526575221140809